Calcium folinate pentahydrate
Ivonescimab
Sun Yat-sen UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the Ivonescimab cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Irinotecan Sun Yat-sen University | Phase 2 | CCC |
FLUOROURACILUM Sun Yat-sen University | Phase 2 | CCC |
(+)-VINCRISTINE Sun Yat-sen University | Phase 2 | CCC |
Ivonescimab Sun Yat-sen University | Phase 2 | CCC |
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →